BlackRock, Inc. 13D and 13G filings for Paratek Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-08 4:57 pm Sale | 2022-06-30 | 13G | Paratek Pharmaceuticals, Inc. PRTK | BlackRock Inc. BLK | 869,224 1.600% | -2,108,456 (-70.81%) | Filing |
| 2022-02-02 7:11 pm Sale | 2021-12-31 | 13G | Paratek Pharmaceuticals, Inc. PRTK | BlackRock Inc. BLK | 2,977,680 5.900% | -469,649 (-13.62%) | Filing |
| 2021-01-29 5:22 pm Purchase | 2020-12-31 | 13G | Paratek Pharmaceuticals, Inc. PRTK | BlackRock Inc. BLK | 3,447,329 7.600% | 1,123,417 (+48.34%) | Filing |